Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

Opioid-induced hypogonadism: why and how to treat it.

De Maddalena C, Bellini M, Berra M, Meriggiola MC, Aloisi AM.

Pain Physician. 2012 Jul;15(3 Suppl):ES111-8. Review.

2.

The endocrine effects of long-term oral opioid therapy: a case report and review of the literature.

Elliott JA, Horton E, Fibuch EE.

J Opioid Manag. 2011 Mar-Apr;7(2):145-54. Review.

PMID:
21561038
3.

The effect of opioid therapy on endocrine function.

Brennan MJ.

Am J Med. 2013 Mar;126(3 Suppl 1):S12-8. doi: 10.1016/j.amjmed.2012.12.001. Review.

PMID:
23414717
4.

Hypogonadism in men with chronic pain linked to the use of long-acting rather than short-acting opioids.

Rubinstein AL, Carpenter DM, Minkoff JR.

Clin J Pain. 2013 Oct;29(10):840-5. doi: 10.1097/AJP.0b013e31827c7b5d.

PMID:
24384986
5.

Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients.

Aloisi AM, Ceccarelli I, Carlucci M, Suman A, Sindaco G, Mameli S, Paci V, Ravaioli L, Passavanti G, Bachiocco V, Pari G.

Reprod Biol Endocrinol. 2011 Feb 18;9:26. doi: 10.1186/1477-7827-9-26.

6.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
7.

Prevalence and influence of diagnostic criteria in the assessment of hypogonadism in intrathecal opioid therapy patients.

Duarte RV, Raphael JH, Labib M, Southall JL, Ashford RL.

Pain Physician. 2013 Jan;16(1):9-14.

8.

Opioid-induced androgen deficiency (OPIAD).

Smith HS, Elliott JA.

Pain Physician. 2012 Jul;15(3 Suppl):ES145-56. Review.

9.
10.

Hypogonadism in patients treated with intrathecal morphine.

Finch PM, Roberts LJ, Price L, Hadlow NC, Pullan PT.

Clin J Pain. 2000 Sep;16(3):251-4.

PMID:
11014399
11.

Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids.

Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, Kaur G, Bruera E.

Cancer. 2004 Feb 15;100(4):851-8.

12.

The impact of opioids on the endocrine system.

Katz N, Mazer NA.

Clin J Pain. 2009 Feb;25(2):170-5. doi: 10.1097/AJP.0b013e3181850df6. Review.

PMID:
19333165
13.

Testosterone supplementation therapy for older men: potential benefits and risks.

Gruenewald DA, Matsumoto AM.

J Am Geriatr Soc. 2003 Jan;51(1):101-15; discussion 115. Review.

PMID:
12534854
14.

Testosterone replacement therapy for the primary care physician.

Casey RW, Barkin J.

Can J Urol. 2008 Aug;15 Suppl 1:71-7; discussion 77. Review.

PMID:
18700068
15.

Hypogonadism associated with long-term opioid therapy: A systematic review.

Birthi P, Nagar VR, Nickerson R, Sloan PA.

J Opioid Manag. 2015 May-Jun;11(3):255-78. doi: 10.5055/jom.2015.0274. Review.

PMID:
25985810
16.

Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.

Arver S, Dobs AS, Meikle AW, Caramelli KE, Rajaram L, Sanders SW, Mazer NA.

Clin Endocrinol (Oxf). 1997 Dec;47(6):727-37.

PMID:
9497881
17.

Androgen therapy in the aging male.

Lunenfeld B.

World J Urol. 2003 Nov;21(5):292-305. Epub 2003 Oct 24. Review.

PMID:
14576959
18.

Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.

Trescot AM, Helm S, Hansen H, Benyamin R, Glaser SE, Adlaka R, Patel S, Manchikanti L.

Pain Physician. 2008 Mar;11(2 Suppl):S5-S62. Review.

19.

[Testosterone substitution in patients with hypogonadism].

Martínez Portillo FJ, Cueva Martínez A, Martin Braun P, Fernández Arancibia MI, Jünemann KP, Alken P.

Arch Esp Urol. 2002 Sep;55(7):827-38. Review. Spanish.

PMID:
12380312
20.

Effects of testosterone treatment on bone mineral density in hypogonadal men receiving intrathecal opioids.

Finch PM, Price LM, Pullan PT, Drummond PD.

Pain Pract. 2015 Apr;15(4):308-13. doi: 10.1111/papr.12190. Epub 2014 Apr 1.

PMID:
24690205
Items per page

Supplemental Content

Write to the Help Desk